Industry: Biotechnology

Biometric Flock Solutions

We solve sheep farmers’ deepest problems by automating flock monitoring through biometric sensor and machine-learning technology. 

Compliant Metal Disc

Artificial Discs have been making innovations to better be able to match the biomechanics of the natural discs they are replacing. Making one out of a compliant metal device instead of a viscoelastic polymer could be the next leap of innovation.

MultiFlex neurovascular catheter

In order to solve an ongoing problem in neurovascular surgery, we developed the MultiFlex catheter: a variable stiffness endovascular catheter. The Multiflex catheter is able to alter its stiffness profile according to the needs of neurovascular surgeons during intervention.

HIVE Medical

HIVE makes it safer to take IV antibiotics at home. When patients miss their doses, their infections can become life-threatening. We are arming clinicians with a smart IV device that empowers them to objectively and continuously monitor the progress of their patients.

GenAssist, Inc.

We regrow muscle to heal traumatic muscle loss injuries. Current treatments are ineffective. 60% of these injuries are left untreated, 30% require a muscle transplant, and 10% are amputated. In contrast, our product recovers 52% of original muscle strength in 4 weeks.

Compass

Compass is a platform that streamlines patient intake, scheduling, & follow-up via SMS, allowing patients the benefits of asynchronous and automated scheduling that can happen faster than the existing, cumbersome process of calling or physically visiting a clinic.

NeuroKX

NeuroKX is leading the next generation of brain inspired hyper-computing devices with applications in a tremendous amount of industries. We aim to research, develop, and commercialize the technology based on the experiment and theory of nano-brain by Dr.Anirban Bandyopadhyay.

HSpeQ – Hyperspectral Imaging

HSpeQ is a hyperspectral software development company with the key mission to analyze data deeper and faster to discover features hidden within 3D dataset. 

AluOmics: Sequencing-free Neoantigen Discovery

AluOmics is developing a low-cost, rapid and scalable approach to defining therapeutically actionable neoantigens within a tumor. Our asset’s uniquely facile implementation will reduce complexity in neoantigen discovery without compromising insight into the patient’s cancer.

Scroll to Top

Login to the IdeaBounce®